Clinical trial
Evaluation of Contrast-enhanced Ultrasound Imaging for the Early Estimate of…
NCT00489697 · University Hospital, Tours, Other · Completed
Key facts
| NCT number | NCT00489697 |
|---|---|
| Title | Evaluation of Contrast-enhanced Ultrasound Imaging for the Early Estimate of Bevacizumab Effect on Colorectal Cancer Liver Metastases |
| Official title | Medical and Economical Evaluation of Contrast-enhanced Ultrasound Imaging for the Early Estimate of Bevacizumab Effect on Colorectal Cancer Liver Metastases |
| Lead sponsor | University Hospital, Tours, Other |
| Status | Completed |
| Study type | Interventional |
| Conditions | Metastatic Colorectal Cancer |
| Intervention type | Device |
| Interventions | real-time contrast-enhanced ultrasound imaging (CEUS) |
| Enrollment | 200 |
| Start date | Jan 1, 2007 |
| Primary completion | Nov 1, 2012 |
| Completion | Nov 1, 2012 |
| First posted | Jun 21, 2007 |
| Last update posted | Jan 4, 2017 |
| Countries | France |
At a glance
- 10–99 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: